Lab to Pilot Scale Challenges – Page 8 – Pharma.Tips

How to Prevent Scale-Up Surprises Before the First Commercial Batch

In our case study, a cutting-edge biopharmaceutical company faced unexpected fluctuations in yield during a pilot batch development meant to validate a new biologic drug. The batch, intended to be…

How to Prevent Scale-Up Surprises Before the First Commercial Batch

Preventing Surprises in Scale-Up from Lab to Pilot Batch Production Scaling up pharmaceutical processes from lab to pilot scale presents inherent challenges that can lead to unexpected outcomes. In this…

Lab-to-Pilot Scale-Up Lessons for MSAT and Validation Teams

Overcoming Lab to Pilot Scale Challenges in Pharmaceutical Manufacturing Transferring processes from a laboratory scale to a pilot scale can present significant hurdles for pharmaceutical professionals. As MSAT (Manufacturing Science…

Lab-to-Pilot Scale-Up Lessons for MSAT and Validation Teams

Detecting initial symptoms during the lab-to-pilot transition is crucial for timely intervention. Common indicators that signify potential scale-up challenges include:Click to read the full article.